小兒學科

研究成果

每年研究成果 1979 2021

• 4771 引文
• 33 h-指數
• 384 文章
• 10 快報
• 10 回顧型文獻
• 6 章節
• 11 更多
  • 6 評論/辯論
  • 2 社論
  • 1 會議摘要
  • 1 簡短的問卷調查
  • 1 專利

每年研究成果

每年研究成果

搜尋結果

• 2021

  Correction to: Micronized sacchachitin promotes satellite cell proliferation through TAK1-JNK-AP-1 signaling pathway predominantly by TLR2 activation (Chinese Medicine, (2020), 15, 1, (100), 10.1186/s13020-020-00381-3)

  Wu, MH. H., Lin, CY. Y., Hou, CY. Y., Sheu, MT. T. & Chang, H., 十二月 2021, 於: Chinese Medicine (United Kingdom). 16, 1, 17.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

  • Transcription Factor AP-1
  • University Hospitals
  • Medicine
  • Cell Proliferation
  • Publications
• 2018

  Corrigendum to ’ Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.’: [European Journal of Pharmacology 700 (2013) 65-73] (S0014299912010345) (10.1016/j.ejphar.2012.12.017))

  Chen, C. H., Cheng, C. Y., Chen, Y. C., Sue, Y. M., Hsu, Y. H., Tsai, W. L. & Chen, T. H., 一月 15 2018, 於: European Journal of Pharmacology. 819, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  • Rosuvastatin Calcium
  • Prostaglandins E
  • Epoprostenol
  • Emotions
  • Medicine
• 2017

  Corrigendum to “Morbidity and mortality of very low birth weight infants in Taiwan—Changes in 15 years: A population based study” [Journal of the Formosan Medical Association 115 (2016) 1039–1045](S0929664616303461)(10.1016/j.jfma.2016.10.011)

  Su, Y. Y., Wang, H. S., Chou, H. C., Chen, C. Y., Hsieh, W. S., Tsao, P. N., Tsou, K. I., Hsu, C. H., Mu, S. C., Lin, C. H., Huang, C. C. & Hsieh, K. S., 六月 1 2017, 於: Journal of the Formosan Medical Association. 116, 6, p. 494 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  • Very Low Birth Weight Infant
  • Survival Rate
  • Morbidity
  • Mortality
  • Birth Weight
• 2016

  Corrigendum to: “Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation” (European Journal of Pharmacology (2012) 689(1–3) (65–71) (S0014299912005201) (10.1016/j.ejphar.2012.06.008))

  Hsu, Y-H., Cheng, C-Y., Chen, Y. C., Chen, T-H., Sue, Y-M., Tsai, W. L. & Chen, C-H., 十二月 5 2016, 於: European Journal of Pharmacology. 792, p. 79 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  • Internal Medicine
  • Leptin
  • Dinoprostone
  • Nephrology
  • Medicine
• 2013

  Correction: Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities (PLoS ONE)

  Chen, Y. J., Chang, S. C., Tsao, K. C., Shih, S. R., Yang, S. L., Lin, T-Y. & Huang, Y. C., 六月 21 2013, 於: PLoS One. 8, 6

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
• 2007

  Erratum: Viral load in blood is correlated with disease severity of neonatal coxsackievirus B3 infection: Early diagnosis and predicting disease severity is possible in severe neonatal enterovirus infection (Tissue Engineering (2007) 44, (e78-e81))

  Yen, M. H., Tsao, K. C., Huang, Y. C., Huang, C. G., Huang, Y. L., Lin, R., Chang, M. L., Huang, C. C., Yan, D. C. & Lin, T-Y., 七月 1 2007, 於: Clinical Infectious Diseases. 45, 1, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審